[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [RiskMitigation](https://github.com/mm80843/T3.5/tree/main/docs/RiskMitigation/index.md) >> Individual ID:PBN__RiskMitigation_429 

# __Phase ii relaxation__

## Category to which it belongs

* [Investigating droplet physics, improving surveillance, addressing over-exposure, international collaboration, raising awareness, and more for a comprehensive response to the pandemic.](https://github.com/mm80843/T3.5/blob/main/docs/PBNCategory/PBN__PBNCategory_459.md)

## Closest similar item

* [Phase iii relaxation](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_430.md)
* [Phase iii relaxation - part 2](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_5055.md)
* [Phase iii relaxation - part 1](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_5054.md)
* [Phase i relaxation](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_428.md)
* [Concentration methods](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3140.md)
* [Bipolar ionization](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1352.md)
* [Concentration method](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3144.md)
* [Differential pressurization](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_5056.md)
* [Optimal thermal environments](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_150.md)
* [Optimizing experimental conditions](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2987.md)

## Benefits linked to a risk

* [Transmission reduction](https://github.com/mm80843/T3.5/blob/main/docs/Benef/PBN__Benef_419.md)

## Risks possibly mitigated by this Mitigation

* [Uncontrolled sars-cov-2 transmission](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_330.md)

